Before enrolling with Trimi or any compounded GLP-1 telehealth platform, verify: the named clinical entity responsible for prescribing decisions and whether you can independently confirm its licensing
Absolute contraindications to GLP-1 receptor agonists with the boxed warning include patients with a personal history of MTC, family history of MTC, or known MEN 2 syndrome
Weight management with GLP-1 medications is typically ongoing
Blood sugar regulation and insulin response Energy burning and heat production (thermogenesis) Appetite signals and feeling of fullness How the body stores and breaks down fat Comparing single vs dual vs triple receptor effects Long-term studies with weekly dosing For laboratory research use only
A clinician can review the patients condition, medications, allergies, medical history, lab markers when appropriate, recovery goals, and red flags
Longer treatment might be needed for the improvement in liver fat and metabolic features to translate into improved fibrosis via slowing disease progression
